CFMEE(SH:688630) Ju Chao Zi Xun·2026-02-25 08:14Core Viewpoint - The company, Chipone Microelectronics, reported impressive financial results for the year 2025, showcasing significant growth in key financial metrics and demonstrating strong resilience in its development [2][3]. Financial Performance - In 2025, Chipone Microelectronics achieved total revenue of 1.408 billion yuan, a substantial year-on-year increase of 47.61% [3]. - The net profit attributable to the parent company reached 290 million yuan, marking an extraordinary year-on-year surge of 80.42% [3]. - The net profit, excluding non-recurring gains and losses, also recorded a rapid growth of 86.00%, with basic earnings per share reaching 2.20 yuan, up 78.86% year-on-year [3]. Profitability and Growth Drivers - The profit growth rate significantly outpaced the revenue growth, indicating a qualitative change in the company's profitability, driven by an increase in the proportion of high-end products and effective cost dilution due to scale effects [3]. - The company's high growth is attributed to its strategic focus, particularly in the PCB and semiconductor sectors, where its core competitiveness has been further enhanced [3]. Strategic Initiatives - In the PCB sector, the company has been continuously upgrading its high-end LDI (Laser Direct Imaging) equipment to meet high-end market demands, resulting in strong order volumes [3]. - In the semiconductor sector, the company has expanded its product matrix, with the WLP series equipment achieving mass delivery and supporting leading manufacturers in production, becoming a new growth driver [3]. Global Expansion - The establishment of a subsidiary in Thailand has allowed the company to play a pivotal role in regional operations and services in Southeast Asia, leading to a positive trend in orders from this market [4]. - The company's products are also being exported to multiple countries and regions, including Japan and Vietnam, significantly enhancing its global brand influence and market share [4]. Financial Health - As of the end of the reporting period, the company's total assets reached 3.117 billion yuan, an increase of 11.75% from the beginning of the period [4]. - The equity attributable to the parent company was 2.308 billion yuan, reflecting an 11.92% growth from the start of the period, indicating a solid financial structure to support future capacity expansion, R&D investment, and further global strategic deepening [4].